Press Releases

Rapalogix Health Receives Catalyst Award for the Most Disruptive Innovation at the Aesthetic & Anti-Aging Medicine World Congress (AMWC) in Monaco
Monaco, April 2, 2026 — Rapalogix Health, a biotechnology company advancing a science-first approach to cellular longevity and skin health, announced today that it has received the Catalyst Award at the Aesthetic & Anti-Aging Medicine World Congress (AMWC) in Monaco. The AMWC is one of the most competitive and globally recognized forums for innovation in medical aesthetics and anti-aging medicine, drawing leading dermatologists, plastic surgeons, and longevity scientists from around the world. The Catalyst Award for the Most Disruptive Innovation recognizes emerging companies demonstrating exceptional promise across four core criteria:... Read more...
Rapalogix Health Wins 2026 Beauty & Longevity CHOICE Awards for Start-up of the Year and Cellular Signaling & Advanced Longevity Mechanisms at the INNOCOS Beauty, Tech & Longevity Summit
San Jose, California, February 21, 2026 — Rapalogix Health, a biotechnology company advancing a science-first approach to cellular longevity and skin health, announced today that it has received 2026 Beauty & Longevity CHOICE Awards for “Start-Up Of The Year” and “Cellular Signaling & Advanced Longevity Mechanisms” at the 2026 INNOCOS Beauty, Tech & Longevity Summit: The Future of Intelligent Beauty, Silicon Valley. The INNOCOS Beauty & Longevity CHOICE Awards is an annual program celebrating innovation at the intersection of beauty, wellness, and technology, judged by a distinguished panel of scientists, longevity... Read more...
Rapalogix Health Wins First Place, Start-Up of the Year, at IMCAS Innovation Tank 2026
Paris, France – January 30, 2026 — Rapalogix Health announced today that it has been awarded First Place, Start-Up of the Year at the prestigious IMCAS Innovation Tank 2026, held during the IMCAS World Congress in Paris. The Congress drew nearly 22,000 global delegates and showcased groundbreaking treatments and state-of-the-art technologies shaping the future of medical aesthetics. The IMCAS Innovation Tank is one of the most competitive global showcases for emerging technologies in dermatology, plastic surgery, and aging science. The 2026 session featured 12 international finalists, selected to present breakthrough solutions... Read more...
Rapalogix Health Receives Judges’ Choice Award at Octane’s 7th Annual Aesthetics Tech Forum
New York, New York, January 26, 2026— Rapalogix Health, a biotechnology company advancing a science-first approach to cellular longevity and skin health, announced today that it received the Judges’ Choice Award at Octane’s 7th Annual Aesthetics Tech Forum: Forging the Future of Aesthetics. The award was presented during Octane’s Capital & Growth Company Presentations, a competitive pitch forum recognizing companies with platforms built for long-term clinical relevance. This year’s judging emphasized durability as the true measure of innovation quality, highlighting biology-driven approaches with clear paths to real-world translation. Rapalogix Health... Read more...